Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-05 11:49 am Sale | 2025-09-30 | 13G | Viking Therapeutics, Inc. VKTX | FMR LLC | 5,772,051 5.100% | -3,995,847 (-40.91%) | Filing History |
| 2025-08-06 12:19 pm Sale | 2025-06-30 | 13G | Viking Therapeutics, Inc. VKTX | FMR LLC | 9,767,898 8.700% | -1,481,440 (-13.17%) | Filing History |
| 2025-05-12 10:43 am Sale | 2025-03-31 | 13G | Viking Therapeutics, Inc. VKTX | FMR LLC | 11,249,337 10.000% | -3,755,003 (-25.03%) | Filing History |
| 2025-04-23 10:00 am Sale | 2025-03-31 | 13G | Viking Therapeutics, Inc. VKTX | BlackRock Inc. BLK | 5,031,511 4.500% | -841,131 (-14.32%) | Filing History |
| 2025-02-04 3:45 pm Purchase | 2024-12-31 | 13G | Viking Therapeutics, Inc. VKTX | BlackRock Inc. BLK | 5,872,642 5.300% | 408,663 (+7.48%) | Filing History |
| 2024-11-14 4:30 pm Sale | 2024-09-30 | 13G | Viking Therapeutics, Inc. VKTX | VIKING GLOBAL INVESTORS LP | 721,926 0.600% | -4,423,186 (-85.97%) | Filing History |
| 2024-11-12 5:54 pm Unchanged | 2024-09-30 | 13G | Viking Therapeutics, Inc. VKTX | The Vanguard Group | 10,167,614 9.170% | 0 (Unchanged) | Filing History |
| 2024-11-04 1:54 pm Purchase | 2024-09-30 | 13G | Viking Therapeutics, Inc. VKTX | The Vanguard Group | 10,167,614 9.170% | 4,785,710 (+88.92%) | Filing History |
| 2024-10-18 12:26 pm Sale | 2024-09-30 | 13G | Viking Therapeutics, Inc. VKTX | STATE STREET CORP STT | 4,666,157 4.200% | -1,066,833 (-18.61%) | Filing History |
| 2024-08-07 4:10 pm Sale | 2024-07-31 | 13G | Viking Therapeutics, Inc. VKTX | BlackRock Inc. BLK | 5,463,979 4.900% | -2,141,888 (-28.16%) | Filing History |
| 2024-02-14 10:13 am Sale | 2023-12-31 | 13G | Viking Therapeutics, Inc. VKTX | VIKING GLOBAL INVESTORS LP | 5,145,112 5.100% | -713,420 (-12.18%) | Filing History |
| 2024-02-13 5:17 pm Purchase | 2023-12-29 | 13G | Viking Therapeutics, Inc. VKTX | The Vanguard Group | 5,381,904 5.380% | 5,381,904 (New Position) | Filing History |
| 2024-02-09 10:05 am Purchase | 2024-02-08 | 13G | Viking Therapeutics, Inc. VKTX | FMR LLC | 15,004,340 14.999% | 4,081,593 (+37.37%) | Filing History |
| 2024-01-26 11:49 am Purchase | 2023-12-31 | 13G | Viking Therapeutics, Inc. VKTX | BlackRock Inc. BLK | 7,605,867 7.600% | 6,178,646 (+432.91%) | Filing History |
| 2024-01-24 1:24 pm Purchase | 2023-12-31 | 13G | Viking Therapeutics, Inc. VKTX | STATE STREET CORP STT | 5,732,990 5.730% | 5,486,148 (+2222.53%) | Filing History |
| 2024-01-12 4:26 pm Sale | 2023-12-31 | 13G | Viking Therapeutics, Inc. VKTX | Millennium Management LLC | 403,556 0.400% | -4,425,644 (-91.64%) | Filing History |
| 2023-11-02 4:30 pm Purchase | 2023-10-23 | 13G | Viking Therapeutics, Inc. VKTX | VIKING GLOBAL INVESTORS LP | 5,858,532 5.900% | 5,858,532 (New Position) | Filing History |
| 2023-04-10 09:37 am Purchase | 2023-04-06 | 13G | Viking Therapeutics, Inc. VKTX | FMR LLC | 10,922,747 11.418% | 8,736,380 (+399.58%) | Filing History |
| 2023-03-30 4:08 pm Sale | 2023-03-28 | 13D | Viking Therapeutics, Inc. VKTX | LIGAND PHARMACEUTICALS INC LGND | 3,616,077 4.600% | -2,449,003 (-40.38%) | Filing History |
| 2023-02-14 5:28 pm Sale | 2021-12-31 | 13G | Viking Therapeutics, Inc. VKTX | ArrowMark Colorado Holdings LLC | 15,931 0.020% | -7,044,872 (-99.77%) | Filing History |